Market Cap : 7.43 B | Enterprise Value : 6.38 B | PE Ratio : | PB Ratio : 8.76 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Ionis Pharmaceuticals's Other Current Receivables for the quarter that ended in Dec. 2020 was $76.2 Mil.
Ionis Pharmaceuticals's quarterly Other Current Receivables increased from Jun. 2020 ($27.83 Mil) to Sep. 2020 ($38.98 Mil) and increased from Sep. 2020 ($38.98 Mil) to Dec. 2020 ($76.20 Mil).
Ionis Pharmaceuticals's annual Other Current Receivables increased from Dec. 2018 ($12.76 Mil) to Dec. 2019 ($63.03 Mil) and increased from Dec. 2019 ($63.03 Mil) to Dec. 2020 ($76.20 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.
No Headline